stockrowKiniksa Pharmaceuticals International, plc
KNSA Healthcare Drug Manufacturers Specialty & Generic
Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024.
- Revenue
- +58.1%
- EPS
- +142.2%
- Free cash flow
- +43.5%
Quarter to September 2026, against a year earlier
Follow KNSA
Alert me
Kiniksa Pharmaceuticals International, plc (KNSA) Net income
Kiniksa Pharmaceuticals International, plc's net income for fiscal 2025 was $59.0M, compared with −$43.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $109.6M. Over the past ten years it has ranged from −$161.9M (fiscal 2019) to $183.4M (fiscal 2022); the current reading is higher than 90% of that period. Kiniksa Pharmaceuticals International, plc ranks 16th of 84 Drug Manufacturers Specialty & Generic companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $59.0M | — |
| FY2024 | −$43.2M | — |
| FY2023 | $14.1M | (92.32%) |
| FY2022 | $183.4M | — |
| FY2021 | −$157.9M | — |
| FY2020 | −$161.4M | — |
| FY2019 | −$161.9M | — |
| FY2018 | −$103.2M | — |
| FY2017 | −$64.9M | — |
| FY2016 | −$24.0M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $47.3M | 86.16% |
| Jun 2026 | $25.4M | 12.57% |
| Mar 2026 | $22.6M | 59.11% |
| Dec 2025 | $14.2M | (22.98%) |
| 35 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. compare | $450.0M |
| RDY Dr. Reddy's Laboratories Ltd compare | $273.0M |
| LNTH Lantheus Holdings, Inc. compare | $269.9M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $209.5M |
| LQDA Liquidia Corporation compare | $138.6M |
| KNSA Kiniksa Pharmaceuticals International, plc | $109.6M |
| ALKS Alkermes plc compare | −$351.0K |
| HIMS Hims & Hers Health, Inc. compare | −$142.0M |
| ELAN Elanco Animal Health Incorporated compare | −$199.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on KNSA
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement